Off topic (sorry) looking for views11 Apr 2020 10:55
I don't know much about Pharma Companies other than AZN, but Gilead has been all over the news this morning with their anti-viral drug success.
Although it is a massive company, the price/earnings is only 17.4 compared with AZN at 90.
If you look at what other pharmas like NCYT have done in the last few weeks, what do you guys think the prospects of a big jump for Gilead are?
To me, it could be pretty big, although with an existing income of £5.16 Billion the impact could be less, and the Chinese have copied the drug, but it must surely be worth a look?